Ad
related to: pharmaceutical sales 30 60 90
Search results
Results From The WOW.Com Content Network
The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange ... 31.90 [113] 30.60 [114] 27.39 [115]
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
Ista Pharmaceutical: $14.6 $11.3 $8.3 $2.6 bromfenac: Xibrom Ocular inflammation Ista Pharmaceutical: $63 $42.1 $20.2 $5.3 hyaluronidase: Vitrase Spreading agent Ista Pharmaceutica: $5.2 $5.2 $4.2 $2.5 rivaroxaban: Xarelto Deep vein thrombosis Johnson & Johnson [39] $1,868 $1,522 $864 $239 $25
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The pharmaceutical industry is a medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications and medical devices. Medications are then administered to (or self-administered by) patients for curing or preventing disease or to alleviate symptoms of illness or injury.
The following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). Transactions are recorded by the highest transaction dollar value (rather than using the inflation adjusted values).
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In 2020 the sales volume of the active pharmaceutical ingredients amounted to 12.5 million euro, which is 3.9 million euros or 46% more than in 2019 In 2020 the Grindeks Group has strengthened its positions in the global pharmaceutical market and exported its products to 93 countries for the total amount of 176.1 million euros.